{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T16:51:56Z","timestamp":1791564716420,"version":"4.3.4"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Goals:<\/jats:title>\n                    <jats:p>To compare outcomes of MASLD in obese and nonobese populations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>MASLD is emerging as one of the leading causes of liver failure and liver-related morbidity and mortality, with an increasing prevalence in the nonobese or lean population. The purpose of this study is to compare hepatic and oncological outcomes between MASLD patients with lean BMI and nonlean BMI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Study:<\/jats:title>\n                    <jats:p>The National Inpatient Sample (NIS) was queried from 2016 to 2020 for adult hospitalizations with MASLD. Exclusion criteria included concurrent diagnoses of viral hepatitis, alcoholic hepatitis, primary biliary cholangitis, hereditary hemochromatosis, autoimmune hepatitis, or Wilson disease. Outcomes of MASLD and its complications were compared between the lean and nonlean subgroups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Patients with lean BMI had higher mortality rates (odds ratio: 2.10,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;0.001). The lean cohort also had higher odds of cirrhosis, portal hypertension, SBP, and ascites. The lean subgroup had higher odds of gastrointestinal malignancies including esophageal cancer, gastric cancer, pancreatic cancer, and colorectal cancer.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Hospitalized lean MASLD patients had higher odds of mortality, \u200b\u200bhepatic morbidities, and gastrointestinal malignancies. These results challenge the use of BMI as a predictor of morbidity and mortality for MASLD patients. Future studies should focus on therapeutic options for MASLD and compare their efficacies between lean and nonlean populations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/mcg.0000000000002153","type":"journal-article","created":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T13:01:31Z","timestamp":1740488491000},"page":"922-926","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Lean Metabolic Dysfunction-Associated Steatotic Liver Disease"],"prefix":"10.1097","volume":"60","author":[{"given":"Chaula","family":"Desai","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, The Brooklyn Hospital Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sweta","family":"Lohani","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, The Brooklyn Hospital Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuj R.","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, The Brooklyn Hospital Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas","family":"Schwartz","sequence":"additional","affiliation":[{"name":"St. George\u2019s University, School of Medicine, Grenada, West Indies"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saigopal R.","family":"Gujjula","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, The Brooklyn Hospital Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adhithya","family":"Baskar","sequence":"additional","affiliation":[{"name":"St. Matthew\u2019s University, School of Medicine, George Town, Cayman Islands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udhaya","family":"Baskar","sequence":"additional","affiliation":[{"name":"Stony Brook University, Stony Brook, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suriya","family":"Baskar","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, The Brooklyn Hospital Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anush","family":"Vasikaran","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Mount Sinai Brooklyn, Brooklyn"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,11]]},"reference":[{"key":"R1-20261009","doi-asserted-by":"crossref","first-page":"100485","DOI":"10.1016\/j.jlr.2023.100485","article-title":"From NAFLD to MASLD: updated naming and diagnosis criteria for fatty liver disease","volume":"65","author":"Rinella","year":"2024","journal-title":"J Lipid Res"},{"key":"R2-20261009","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","article-title":"The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis","volume":"7","author":"Riazi","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"suppl","key":"R3-20261009","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.3350\/cmh.2022.0365","article-title":"Global incidence and prevalence of nonalcoholic fatty liver disease","volume":"29","author":"Teng","year":"2023","journal-title":"Rev Clin Mol Hepatol"},{"key":"R4-20261009","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease\u2014meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"R5-20261009","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1053\/j.gastro.2022.06.023","article-title":"AGA clinical practice update: diagnosis and management of nonalcoholic fatty liver disease in lean individuals: expert review","volume":"163","author":"Long","year":"2022","journal-title":"Gastroenterology"},{"key":"R6-20261009","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0140-6736(03)15268-3","article-title":"Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies","volume":"363","year":"2004","journal-title":"Lancet"},{"key":"R7-20261009","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1210\/jc.2015-3444","article-title":"Body mass index and risk of nonalcoholic fatty liver disease: two electronic health record prospective studies","volume":"101","author":"Loomis","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"R8-20261009","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1016\/j.cgh.2022.06.029","article-title":"Comparative burden of metabolic dysfunction in lean NAFLD vs non-lean NAFLD\u2014a systematic review and meta-analysis","volume":"21","author":"Tang","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R9-20261009","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2024.102569","article-title":"Cardiovascular morbidity and mortality in lean vs. non-lean MASLD: a comprehensive meta-analysis","volume":"49","author":"Nso","year":"2024","journal-title":"Curr Probl Cardiol"},{"key":"R10-20261009","first-page":"134","article-title":"Long-term outcomes in lean and non-lean NAFLD patients: a systematic review and meta-analysis","volume":"85","author":"Huang","year":"2024","journal-title":"Meta-Analysis Endocrine"},{"key":"R11-20261009","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22052350","article-title":"Treatments for NAFLD: state of art","volume":"22","author":"Mantovani","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R12-20261009","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10050943","article-title":"Discordance between body-mass index and body adiposity index in the classification of weight status of elderly patients with stable coronary artery disease","volume":"10","author":"Hudzik","year":"2021","journal-title":"J Clin Med"},{"key":"R13-20261009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1259\/bjr\/38447238","article-title":"The clinical importance of visceral adiposity: a critical review of methods for visceral adipose tissue analysis","volume":"85","author":"Shuster","year":"2012","journal-title":"Br J Radiol"},{"key":"R14-20261009","article-title":"Waist circumference and BMI are strongly correlated with MRI-derived fat compartments in young adults","volume":"11","author":"Pasanta","year":"2021","journal-title":"Life (Basel)"},{"key":"R15-20261009","doi-asserted-by":"crossref","DOI":"10.1038\/s43856-022-00140-5","article-title":"Visceral adiposity is associated with metabolic profiles predictive of type 2 diabetes and myocardial infarction","volume":"2","author":"Raheem","year":"2022","journal-title":"Communications Medicine"},{"key":"R16-20261009","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/hep.22350","article-title":"Visceral fat: a key mediator of steatohepatitis in metabolic liver disease","volume":"48","author":"van der Poorten","year":"2008","journal-title":"Hepatology"},{"key":"R17-20261009","doi-asserted-by":"crossref","DOI":"10.1016\/j.hnm.2023.200210","article-title":"Visceral fat: a key mediator of NAFLD development and progression","volume":"33","author":"Bansal","year":"2023","journal-title":"Human Nutrition and Metabolism"},{"key":"R18-20261009","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1053\/j.gastro.2018.11.021","article-title":"Propensity for intra-abdominal and hepatic adiposity varies among ethnic groups","volume":"156","author":"Lim","year":"2019","journal-title":"Gastroenterology"},{"key":"R19-20261009","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1038\/nutd.2011.2","article-title":"Asian women have greater abdominal and visceral adiposity than Caucasian women with similar body mass index","volume":"1","author":"Lim","year":"2011","journal-title":"Nutr Diabetes"},{"key":"R20-20261009","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1007\/s00535-003-1178-8","article-title":"Increase in the prevalence of fatty liver in Japan over the past 12 years: analysis of clinical background","volume":"38","author":"Kojima","year":"2003","journal-title":"J Gastroenterology"},{"key":"R21-20261009","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2024.101288","article-title":"Lean non-alcoholic fatty liver disease and the risk of all-cause mortality: An updated meta-analysis","volume":"29","author":"Wongtrakul","year":"2024","journal-title":"Ann Hepatol"},{"key":"R22-20261009","first-page":"S","article-title":"Characteristics and long-term prognosis of lean patients with nonalcoholic fatty liver disease","volume":"146","author":"Dela Cruz","year":"2014","journal-title":"Gastroenterology"},{"key":"R23-20261009","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1016\/j.cgh.2022.11.019","article-title":"Mortality and liver-related events in lean versus non-lean nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"21","author":"Ha","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R24-20261009","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/9797841","article-title":"Nonalcoholic fatty liver disease is associated with Helicobacter pylori infection in North Urban Chinese: a retrospective study","volume":"2020","author":"Xu","year":"2020","journal-title":"Gastroenterol Res Pract"},{"key":"R25-20261009","article-title":"Non-alcoholic fatty liver disease and gallstones: a systematic review","volume":"15","author":"Slouha","year":"2023","journal-title":"Cureus"},{"key":"R26-20261009","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1007\/s10620-014-3113-7","article-title":"Nonalcoholic fatty liver disease increases risk for gastroesophageal reflux symptoms","volume":"59","author":"Catanzaro","year":"2014","journal-title":"Dig Dis Sci"},{"key":"R27-20261009","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/HEP.0000000000000329","article-title":"Lean individuals with NAFLD have more severe liver disease and poorer clinical outcomes (NASH-CO Study)","volume":"78","author":"Nabi","year":"2023","journal-title":"Hepatology"},{"key":"R28-20261009","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1007\/s12072-024-10716-z","article-title":"Liver and cardiovascular outcomes in lean non-alcoholic fatty liver disease: an updated systematic review and meta-analysis of about 1 million individuals","volume":"18","author":"Souza","year":"2024","journal-title":"Hepatol Int"},{"key":"R29-20261009","doi-asserted-by":"crossref","DOI":"10.3390\/jcm7120562","article-title":"Lean patients with non-alcoholic fatty liver disease have a severe histological phenotype similar to obese patients","volume":"7","author":"Denkmayr","year":"2018","journal-title":"J Clin Med"},{"key":"R30-20261009","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S2468-1253(20)30077-7","article-title":"Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"5","author":"Ye","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R31-20261009","doi-asserted-by":"crossref","first-page":"e33867","DOI":"10.1097\/MD.0000000000033867","article-title":"Association between nonalcoholic fatty liver disease and colorectal cancer: a population-based study","volume":"102","author":"Wu","year":"2023","journal-title":"Medicine (Baltimore)"},{"key":"R32-20261009","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jhep.2017.09.012","article-title":"Association between non-alcoholic fatty liver disease and cancer incidence rate","volume":"68","author":"Kim","year":"2018","journal-title":"J Hepatol"},{"key":"R33-20261009","doi-asserted-by":"crossref","first-page":"10681","DOI":"10.1038\/s41598-022-14856-w","article-title":"Increased risk of pancreatic cancer in individuals with non-alcoholic fatty liver disease","volume":"12","author":"Park","year":"2022","journal-title":"Sci Rep"},{"key":"R34-20261009","first-page":"1209","article-title":"Extracellular vesicles in fatty liver promote a metastatic tumor microenvironment","volume":"35","author":"Wang","year":"2023","journal-title":"Cancer Metastasis Rev"},{"key":"R35-20261009","first-page":"143","article-title":"Extracellular vesicles and their roles in cancer progression","volume":"2174","author":"Chang","year":"2021","journal-title":"In: Methods Mol Biol"},{"key":"R36-20261009","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1080\/0284186X.2023.2197124","article-title":"Insulin resistance in patients with cancer: a systematic review and meta-analysis","volume":"62","author":"M\u00e0rmol","year":"2023","journal-title":"Acta Oncol"},{"key":"R37-20261009","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1002\/hep.30908","article-title":"Lean NAFLD: a distinct entity shaped by differential metabolic adaptation","volume":"71","author":"Chen","year":"2020","journal-title":"Hepatology"},{"key":"R38-20261009","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"key":"R39-20261009","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/hep.28709","article-title":"Bile acids and nonalcoholic fatty liver disease: molecular insights and therapeutic perspectives","volume":"65","author":"Arab","year":"2017","journal-title":"Hepatology"},{"key":"R40-20261009","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.3748\/wjg.v18.i21.2609","article-title":"Leaky gut and the liver: a role for bacterial translocation in nonalcoholic steatohepatitis","volume":"18","author":"Ilan","year":"2012","journal-title":"World J Gastroenterol"},{"key":"R41-20261009","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/liv.15078","article-title":"Association of genetic variations with NAFLD in lean individuals","volume":"42","author":"Lin","year":"2022","journal-title":"Liver Int"},{"key":"R42-20261009","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1056\/NEJMoa2401943","article-title":"Tirzepatide for metabolic dysfunction-associated steatohepatitis with liver fibrosis","volume":"391","author":"Loomba","year":"2024","journal-title":"N Engl J Med"}],"container-title":["Journal of Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MCG.0000000000002153","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T16:01:32Z","timestamp":1791561692000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MCG.0000000000002153"}},"subtitle":["A Comparative Analysis of Hepatic and Oncological Outcomes"],"short-title":[],"issued":{"date-parts":[[2025,2,24]]},"references-count":42,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/mcg.0000000000002153","relation":{},"ISSN":["1539-2031","0192-0790"],"issn-type":[{"value":"1539-2031","type":"electronic"},{"value":"0192-0790","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2,24]]},"assertion":[{"value":"2024-11-08","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-25","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}